Home > Benefits of plant science > Biotechnology Benefits & Safety Database > Global Status of Commercialized Biotech/GM Crops: 2008

Global Status of Commercialized Biotech/GM Crops: 2008

James C (2008). ISAAA Brief 39.

Bookmark and Share

This paper is relevant to the Socio-Economic, Environmental, Developing Country, and Overview Documents categories in the following areas:

Crops:Wheat, Maize, Cotton, Potato, Soybean, Rice, Oilseed Rape, Sweet Potato, Papaya, and Other
Traits:Insect Resistance, Herbicide Tolerance, and Insect Res. (BT)
Countries:Global
Regions:Middle East, South America, North America, Europe, Australia / NZ, Asia, and Africa
ImpactAreas:Socio-Economic, Environmental, and Developing Countries

Abstract or Summary:

The International Service for the Acquisition of Agri-Biotech Applications (ISAAA) released its annual Global Status of Commercialized Biotech/GM Crops, charting significant adoption milestones in Africa, Latin America, and Asia and growth in approvals of biotech crops globally. 13.3 million farmers in 25 countries grew biotech crops on 125 million hectares in 2008, marking a 9.4% increase over global biotech crop acreage in 2007. 3 countries grew biotech crops for the first time in 2008: Burkina Faso, Egypt and Bolivia.

Download Global Status of Commercialized Biotech/GM Crops: 2008

CropLife International fully acknowledges the source and authors of the publication as detailed above.

Related Papers

Has your visit been useful?